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Background: Mindfulness- and 
acceptance-based interventions are 
increasingly studied as a potential 
treatment for a variety of mental 
conditions.
Objective: To assess the effects of 
mindfulness- and acceptance-based 
interventions on psychotic symp-
toms and hospitalization in 
patients with psychosis 
Methods: MEDLINE/PubMed, 
Embase, the Cochrane Library, and 
PsycINFO were screened from 
inception through April 2015. 
Randomized controlled trials 
(RCTs) were analyzed when they 
assessed psychotic symptoms or 
hospitalization in patients with 
psychosis; affect, acceptance, mind-
fulness, and safety were defined as 
secondary outcomes.
Results: Eight RCTs with a total of 
434 patients comparing mindful-
ness-based (4 RCTs) or acceptance-
based interventions (4 RCTs) to 
treatment as usual or attention con-
trol were included. Six RCTs had 
low risk of bias. Moderate evidence 
was found for short-term effects on 
total psychotic symptoms, positive 
symptoms, hospitalization rates, 
duration of hospitalization, and 
mindfulness and for long-term 
effects on total psychotic symptoms 
and duration of hospitalization. No 
evidence was found for effects on 
negative symptoms, affect, or accep-
tance. No serious adverse events 
were reported.
Conclusion: Mindfulness- and accep-
tance-based interventions can be rec-
ommended as an additional treat-








方法：从开始到 2015 年 4 月筛
选了MEDLINE/PubMed、Embase, 
























Antecedentes: Las intervenciones 
basadas en la conciencia plena y la 
aceptación se estudian cada vez 
más como posible tratamiento 
para varios trastornos mentales.
Objetivo: Evaluar los efectos de 
las intervenciones basadas en la 
conciencia plena y la aceptación 
en los síntomas psicóticos y en la 
hospitalización de los pacientes 
con psicosis 
Métodos : Se examinaron 
MEDLINE/PubMed, Embase, la 
bibliografía de Cochrane y 
PsycINFO desde su creación hasta 
abril de 2015. Se analizaron los 
ensayos aleatorizados comparati-
vos (EAC) que evaluaban los sínto-
mas psicóticos o la hospitalización 
de los pacientes con psicosis; como 
resultados secundarios se definier-
on el afecto, la aceptación, la con-
ciencia plena y la seguridad.
Resultados: Se incluyeron ocho 
EAC con un total de 434 pacientes 
que comparaban las intervencio-
nes basadas en la conciencia plena 
(4 EAC) o las intervenciones basa-
das en la aceptación (4 EAC) con el 
tratamiento normal o con el con-
trol de atención. Seis EAC tuvieron 
un bajo riesgo de sesgos. Se obser-
varon evidencias moderadas para 
los efectos a corto plazo de los sín-
tomas psicóticos totales, los sínto-
mas positivos, los índices de hospi-
talización, la duración de la hospi-
talización y la conciencia plena y 
para los efectos a largo plazo de los 
síntomas psicóticos totales y la 
duración de la hospitalización. No 
se observaron evidencias en los 
efectos sobre los síntomas negati-
vos, el afecto o la aceptación. No se 
comunicaron acontecimiento 
adversos graves.
Conclusión: Las intervenciones 
basadas en la conciencia plena y la 
aceptación pueden recomendarse 
como tratamiento adicional para 
los pacientes con psicosis.
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INTRODUCTION
Psychotic disorders are severe mental conditions 
that typically manifest themselves mainly by positive 
symptoms (delusions and hallucinations) and negative 
symptoms (lack of motivation, reduction in spontane-
ous speech, and social withdrawal).1,2 These disorders 
are typically chronic in nature and often restrict quali-
ty of life and social function.3-5 Even when patients are 
compliant to psychopharmaceutical treatment, symp-
toms, especially negative symptoms, often persist,2,6 
and about 30% of patients are therapy refractory.7 
Mindfulness- and acceptance-based interventions 
are increasingly studied as a potential treatment for a 
variety of physical8-11 and mental conditions.10,12,13 
Despite conceptual differences between different 
acceptance- and mindfulness-based interventions, 
they share many theoretical underpinnings. These 
approaches do not try to alter the content of dysfunc-
tional thoughts and symptoms but to alter the patients’ 
relationship towards these thoughts and symptoms. A 
mindful and accepting observation of every pleasant 
or unpleasant experience (including thoughts) in the 
present moment is intended.14,15 However, the specific 
techniques that are used to achieve this goal differ 
between different approaches.13 Primarily mindful-
ness-based interventions like mindfulness-based cog-
nitive therapy (MBCT) or mindfulness-based stress 
reduction (MBSR) that are more or less direct transla-
tions of Buddhist mindfulness traditions into Western 
medicine use formal mindfulness training like sitting 
or walking meditation as a main intervention.15,16 
While MBSR has been originally designed as an inter-
vention for chronic pain and stress-related symptoms, 
MBCT combines MBSR with cognitive-behavioral 
therapy and is normally led by a trained therapist.15,16 
MBCT thus focuses more on a therapeutic approach 
rather than general stress reduction.16 On the other 
hand, primarily acceptance-based interventions like 
acceptance and commitment therapy (ACT) or accep-
tance-based behavior therapy (ABBT) are multimodal 
approaches that have integrated cognitive interven-
tions into a theoretical framework of mindfulness and 
acceptance and include shorter and more informal 
mindfulness exercise.13,14,17 Another major difference 
between primarily mindfulness-based and primarily 
acceptance-based intervention is that the former are 
mostly offered as group sessions16  and the latter 
mostly as individual sessions.14
As patients with psychotic disorders frequently 
engage in avoidance strategies like substance abuse or 
distraction—or on the other extreme, may become 
engrossed by their symptoms—mindfulness- and 
acceptance-based interventions have been proposed 
as approaches to alter the patients’ relationship 
towards their symptoms and hence reduce symptom-
related distress.18
The aim of this systematic review and meta-analy-
sis was to investigate whether mindfulness- and accep-
tance-based interventions are effective and safe inter-
ventions for reducing psychotic symptoms and hospi-
talization in patients with psychosis.
METHODS
Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) guidelines for systematic 
reviews and meta-analyses19 and the recommenda-
tions of the Cochrane Collaboration20 were followed.
Eligibility Criteria
Types of Studies
Randomized controlled trials (RCTs) were eligible. 
No language restrictions were applied.
Types of Participants
Adults with psychotic disorders (ie, schizophrenia, 
schizoaffective disorder, schizophreniform disorder, 
delusional disorder, brief psychotic disorder, and psy-
chotic disorder not otherwise specified) were eligible if 
they were diagnosed by 
1. the Diagnostic and Statistical Manual, 4th Edition, 
Revised (DSM-IVR),1 the Research Diagnostic 
Criteria (RDC),21 or the International Classification 
of Disease22 (ICD)22;
2. any other clinician-based diagnosis criterion; or
3. unclear diagnostic criteria but were currently 
treated for psychotic disorders.
Studies involving participants with comorbid phys-
ical or mental disorders were eligible for inclusion.
Types of Interventions
Experimental
1. Acceptance-based interventions such as ACT or 
ABBT14,17 or
2. mindfulness-based interventions such as MBCT or 
MBSR15,16 were eligible.
Other, less common interventions were also eligible 
if they were clearly based on mindfulness or acceptance.
Control
1. Treatment as usual,
2. attention control, or
3. other active nonpharmacological interventions 
were eligible.
Types of Outcome Measures
To be eligible, RCTs had to assess at least 1 primary 
outcome:
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1. improvement in the severity of symptoms of psy-
chosis, measured by clinician-rated scales, such as 
the Brief Psychiatric Rating Scale,23 the Positive and 
Negative Syndrome Scale,24 the Clinical Global 
Impression Scale,25 or any other validated scale; or
2. hospitalization, assessed as number of hospital-
ized patients or days in hospital in a predefined 
follow-up period.
Secondary outcomes included
1.  affect, assessed as 
a. depressive symptoms, measured by self-rating 
scales such as the Beck Depression Inventory,26 
or by clinician-rated scales, such as the Hamilton 
Rating Scale for Depression27 or any other vali-
dated scale; and
b. anxiety symptoms measured by clinician-rated 
scales, such as the Hamilton Anxiety Scale28 or 
self-report scales such as the Beck Anxiety 
Inventory29 or any other validated scale;
2. acceptance, assessed by validated scales such as the 
Acceptance and Action Questionnaire II30;
3. mindfulness, assessed by validated scales such as the 
Kentucky Inventory of Mindfulness Skills31; and
4. safety of the intervention assessed as amount of 
extrapyramidal symptoms or number of adverse 
events.
Search Methods
Medline/PubMed, Embase, the Cochrane Library, 
and PsycINFO were searched from their inception 
through April 13, 2015. The literature search was con-
structed around search terms for “mindfulness- and accep-
tance-based interventions” and search terms for “psycho-
sis.” For PubMed, the following search strategy was used: 
(Psychotic Disorders[MeSH Terms] OR Paranoid 
Disorders[MeSH Terms]OR Affective Disorders, 
Psychotic[MeSH Terms] OR Psychosis[Title/Abstract] OR 
Psychotic[Title/Abstract] OR Schizophrenia[MeSH Terms] 
OR Schizophrenia[Title/Abstract] OR Schizophrenic[Title/
Abstract] OR Schizoaffective[Title/Abstract]) AND 
(Mindfulness[Title/Abstract] OR MBSR[Title/Abstract] OR 
MBCT[Title/Abstract] OR Acceptance-based[Title/
Abstract] OR (Acceptance[Title/Abstract] AND 
Commitment[Title/Abstract])). The search strategy was 
adapted for each database as necessary. 
Additionally, reference lists of identified original 
articles or reviews were searched manually, and the 
Mindfulness Research Guide (www.mindfulexperi-
ence.org) was screened.
Two review authors independently screened 
abstracts identified during literature search and read 
potentially eligible articles in full to determine wheth-
er they met the eligibility criteria. Disagreements were 
discussed with a third review author until consensus 
was reached.
Data Extraction and Management
Two authors independently extracted data on 
patients (eg, age, gender, diagnosis); interventions (eg, 
type, frequency, duration); control interventions (eg, 
type, frequency, duration); cointerventions; outcomes 
(eg, outcome measures, assessment timepoints); and 
results using an a priori developed data extraction 
form. Discrepancies were discussed with a third review 
author until consensus was reached.
Risk of Bias in Individual Studies
Risk of bias was assessed by 2 review authors inde-
pendently using the risk of bias tool proposed by the 
Cochrane Back Review Group.32 This tool assesses risk 
of bias on the following domains: selection bias, perfor-
mance bias, attrition bias, reporting bias, and detection 
bias using 12 criteria as (1) low risk of bias, (2) unclear 
risk of bias, or (3) high risk of bias. Discrepancies were 
discussed with a third review author until consensus is 
reached. Studies that met at least 6 of the 12 criteria and 
had no serious flaws were rated as having low risk of 
bias. Studies that met fewer than 6 criteria or had a seri-
ous flaw were rated as having high risk of bias.32
Data Analysis
Assessment of Effect Size
Separate meta-analyses were planned for
1. short-term (outcome measures taken closest to 4 
weeks after the intervention) and long-term effects 
(closest to 12 months after the intervention) and
2. different control interventions (treatment as usual, 
attention control, other) using Review Manager 5 
software (Version 5.2, The Nordic Cochrane Centre, 
Copenhagen) by a random effects model.20 Meta-
analyses were conducted if at least 2 RCTs for a spe-
cific comparison were available.20
For continuous outcomes, standardized mean dif-
ferences (SMDs) with 95% confidence intervals (CIs) 
were calculated as the difference in means between 
groups divided by the pooled standard deviation. A 
negative SMD was defined as indicating beneficial 
effects of the intervention compared to the control 
intervention for symptoms and affect while a positive 
SMD was defined to indicate beneficial effects for 
acceptance and mindfulness. If necessary, scores were 
inverted by subtracting the mean from zero.20
To evaluate the magnitude of the overall effect 
size, Cohen’s categories were used with (1) SMD=0.2 to 
0.5, small; (2) SMD=0.5 to 0.8, moderate; and (3) 
SMD>0.8, large effect sizes.33
For dichotomous outcomes, risk ratios (RRs) with 
95% CI were calculated by dividing the risk of event 
in the experimental group (ie, the number of partici-
pants with the respective outcome divided by the 
total number of participants) by the risk of event in 
the control group.20
Levels of evidence were determined using the van 
Tulder recommendations as (1) strong evidence: con-
sistent findings among multiple RCTs with low risk of 
bias; (2) moderate evidence: consistent findings among 
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multiple high-risk RCTs and/or 1 low-risk RCT; (3) lim-
ited evidence: 1 RCT with high risk of bias; (4) conflict-
ing evidence: inconsistent findings among multiple 
RCTs; and (5) no evidence: no RCTs.34
Assessment of Heterogeneity
To analyze statistical heterogeneity between stud-
ies, the I2 statistics, a measure of how much variance 
between studies can be attributed to differences between 
studies rather than chance, was calculated. The magni-
tude of heterogeneity was categorized as (1) I2=0%-25%, 
low heterogeneity; (2) I2=26%-50%, moderate heteroge-
neity; (3) I2=51%-75%, substantial heterogeneity; and (4) 
I2=76%-100%, considerable heterogeneity.35 The chi2 
test was used to assess whether differences in results were 
compatible with chance alone. Given the low power of 
this test when only few studies or studies with low sam-
ple size are included in a meta-analysis, a P value≤0.10 
was regarded to indicate significant heterogeneity.20
Subgroup and Sensitivity Analyses
Subgroup analyses were conducted for 
1. type of intervention (primarily acceptance-based 
such as ACT or ABBT or primarily mindfulness-
based such as MBCT or MBSR) and
2. type of participants (manual-based diagnosis; 
other or unclear diagnosis).
Subgroup differences were tested using a chi2 test 
for heterogeneity across subgroup. I2 statistics for sub-
group differences were computed as the percentage of 
the variance between the different subgroups that is due 
to genuine subgroup differences rather than chance.20
To test the robustness of significant results, sensi-
tivity analyses were conducted for studies with high vs 
low risk of bias. If statistical heterogeneity was present 
in the respective meta-analysis, subgroup and sensitiv-
ity analyses were also used to explore possible reasons 
for heterogeneity.
Risk of Bias Across Studies
Assessment of risk of publication bias was origi-
nally planned by investigation of funnel plot asym-
metry (using Review Manager 5 software) if at least 10 
studies were included in a meta-analysis.36 However, 
as less than 10 studies were included in each meta-
analysis, funnel plots were not analyzed.
RESULTS
Literature Search
Three hundred seventy-two records were retrieved 
in the literature search. Of 247 nonduplicate records, 
238 were excluded because they were not randomized, 
did not include patients with psychosis, and/or did not 
include mindfulness- or acceptance-based interven-
tions. Nine full-text articles on 8 RCTs with a total of 
434 patients were assessed for eligibility.37-45 All 8 
RCTs were included in qualitative analysis and meta-
analysis (Figure 1).
Study Characteristics
Characteristics of the sample, interventions, out-
come assessment, and results are shown in Table 1.
Setting and Participant Characteristics 
Of the 8 RCTs that were included, 2 originated from 
North America,37,40 3 from Europe,39,41,43 2 from Asia,44,45 
and 1 from Australia.42 Patients were recruited from psy-
chiatric hospitals,37,40 outpatient clinics,44,45 mental 
health services,42,43 or patient associations.41 One RCT did 
not state the setting from which patients were recruited.39
Patients in 5 RCTs were diagnosed with psychosis or 
affective disorder with psychotic symptoms according to 
DSM-IV39-42,44,45 or ICD-10,43while patients in 1 RCT had 
a hospital-supplied diagnosis where the diagnostic meth-
od was not specified.37 Between 48.1% and 100% of 
included patients were diagnosed with schizophrenia. 
Mean time since diagnosis ranged from 2.6 years to 17.7 
years. Patients’ mean age ranged from 25.6 years to 41.6 
years; between 22.2% and 45.0% (median: 36.3%) of 
patients in each study were female.
Intervention Characteristics
Four RCTs used mainly acceptance-based interven-
tions.37,40,42,43 Three of those used modifications of the 
ACT treatment manual14 that was modified for patients 
with psychosis. ACT was offered as 4 individual treat-
ment sessions of 45 to 50 minutes each,37 10 individual 
sessions of 60 minutes each,43 or as a varying number of 
individual sessions depending on the individual length 
of hospital stay.40 All ACT interventions included stan-
372 records identified 
through database searching 
 • 90  Medline/PubMed 
• 47  Cochrane 
• 75  Scopus 
• 160  PsychInfo 
238 records excluded
9 full-text articles on 8 studies 
included in quantitative 
synthesis (meta-analysis)
 
247 records after duplicates removed 
 
9 full-text articles assessed for eligibility 
  
9 full-text articles on 8 studies 
included in qualitative synthesis 
  
0 additional records 
identified through 
other sources   
Figure 1	Flowchart	of	the	results	of	the	literature	search.
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dard acceptance and mindfulness exercises as outlined 
in the Hayes et al (1999) protocol14; 1 RCT also included 
a mindfulness breathing exercise.43 The fourth RCT used 
“treatment of resistant command hallucinations” 
(TORCH), an acceptance-based cognitive behavioral 
therapy intervention for command hallucinations.42 
Fifteen individual weekly sessions of 50 minutes each 
and 2 follow-up sessions consisting of belief modifica-
tion and acceptance-based interventions that were based 
on ACT were offered. Additional ACT exercises and 
mindfulness-based exercises were used. Audiotaped 
mindfulness-based exercises aimed to cultivate a non-
judgmental response towards positive psychotic symp-
toms while ACT exercises and metaphors aimed to 
implement a detached acceptance of psychotic symp-
toms. Given that TORCH is a relatively novel interven-
tion, it cannot be regarded as widely accepted.
Four RCTs used mainly mindfulness-based interven-
tions,39,41 1 of those being explicitly based on MBCT.41 
Two interventions used mindfulness meditation and 
awareness exercises such as body scan and mindful 
breathing during 1039 or 841 weekly group sessions of 60 
minutes each. Cognitive and metacognitive elements 
were incorporated, and mindfulness exercises were adapt-
ed for patients with psychosis. The remaining 2 RCTs 
used 12 biweekly sessions (120 minutes each) of a not 
widely accepted mindfulness-based psychoeducation pro-
gram that combined MBSR with psychoeducation.44,45 
In 7 RCTs, the intervention was combined with 
treatment as usual and compared with treatment as 
usual alone as the control intervention. Treatment as 
usual consisted of individual psychopharmacology, case 
management, and psychotherapy in 5 RCTs37,40,43-45; 
patients in 2 RCTs were wait-listed and treatment was 
not specified.39,41 One RCT used befriending as a control 
intervention, a fully manualized attention control inter-
vention without therapeutic component that was 
matched with the experimental intervention for con-
tact time and attention.42
Only 2 RCTs reported on the use of antipsychotic 
medication during the trial period and reported that 
compliance to medication was comparable between 
groups.37,45
Outcome Measures
Severity of symptoms of psychosis was assessed by 
7 RCTs using the Brief Psychiatric Rating Scale,40,44,45 the 
Positive and Negative Syndrome Scale,42,43 the Clinical 
Global Impression Scale,40,41 or the Psychiatric Symptom 
Rating Scale.39 Hospitalization was assessed by 4 RCTs as 
number of hospitalized patients in a predefined follow-
up period37,40 or as mean duration of rehospitalization 
per patient.44,45 Affect was measured by 2 RCTs using 
the Hospital Anxiety and Depression Scale43 or the Brief 
Psychiatric Rating Scale.40 Acceptance was assessed by 
the Acceptance and Action Questionnaire II in 3 RCTs41-
43 and by the Voices Acceptance and Action Scale in 1 
RCT.42 Mindfulness was measured  by the Kentucky 
Inventory of Mindfulness Skills43 or the Southampton 
Mindfulness Questionnaire39,41 in 3 RCTs. Safety was 
assessed as number of adverse events in 2 RCTs.40,43
While all RCTs reported short-term effects, only 4 
RCTs reported long-term effects.38,42,44,45
Risk of Bias in Individual Studies
Six RCTs had low risk of bias,37,40,42-45 and 2 RCTs 
had high risk of bias39,41 (Table 2). Risk of selection bias 
was mixed; only 3 RCTs each reported adequate random-
Table 2	Risk	of	Bias	of	the	Included	Studies
              Bias




























































Unclear Unclear Yes Unclear Unclear Yes Unclear Yes No Yes Yes Yes 6
Chadwick		
et	al	(2009)
No Unclear Unclear Unclear Unclear Yes Unclear Yes No Yes No Yes 4
Chien	&		
Lee	(2013)








Yes No Yes No No Yes Yes Yes Yes Yes No Yes 8
Langer	et		
al	(2012)
Unclear Unclear Yes Unclear Unclear Unclear Unclear No No Yes Yes Yes 4
Shawyer	et	
al	(2012)
No Yes No Unclear Unclear Yes Yes Yes No Yes Yes Yes 7
White	et		
al	(2011)
Yes Yes Yes No No Yes Yes No No Yes Yes Yes 8
aHigher	scores	indicate	lower	risk	of	bias.
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ization or adequate allocation concealment. While no 
RCT reported blinding of participants or providers, all 
but 2 RCTs39,40 reported adequate blinding of outcome 
assessors. All but 1 RCT41 adequately described cointer-
ventions, and 5 RCTs reported acceptable intervention 
compliance. Attrition bias was mixed as all studies had 
an acceptable and described dropout rate but only 3 
RCTs used an intention-to-treat analysis. Risk of report-
ing bias and detection bias was low in all RCTs.
Outcomes
Mindfulness- and Acceptance-based Interventions 
vs Treatment as Usual
Meta-analyses revealed moderate evidence for 
short-term effects on total psychotic symptoms and 
positive symptoms. Heterogeneity was low to moderate 
and—based on Cohen’s categories—effects were of 
small to moderate size (Figure 2). No evidence was found 
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Moderate evidence was found for lower hospitalization 
rates and for shorter duration of hospitalization in the 
intervention groups compared to treatment as usual 
(Figure 2). Regarding secondary outcomes, no evidence 
was found for short-term effects on affect and accep-
tance (Figure 3). There was moderate evidence for short-
term effects on mindfulness. Heterogeneity was low and 
effect size was large (Figure 3).
Moderate evidence for long-term effects (12 to 24 
months after the intervention) on total psychotic 
symptoms and for shorter duration of hospitalization 
in the long term was found in 2 RCTs (Figure 4). 
Further, hospitalization rate at 12 months was assessed 
in 1 RCT.38 This RCT reported reduced hospitalization 
rates in the intervention group compared to the treat-
ment as usual-group (Table 1).
Mindfulness- and Acceptance-based Interventions 
vs Attention Control
One RCT compared an acceptance-based interven-
tion to attention control and found no evidence for short-
term or long-term (6 months after the intervention) 
group differences for total symptoms, positive symp-
toms, negative symptoms, or acceptance42 (Table 1).
Safety
Safety data were reported in 2 RCTs. One RCT 
reported that no adverse events were observed40 and 
the other RCT reported that no “suspected unexpected 
serious adverse events” were observed.43 Two further 
RCTs reported patients that dropped out of the study 
due to health reasons: 1 patient in the treatment arm of 
1 RCT died in a car accident,37,38 and 1 patient in anoth-
er RCT had a heroin addiction relapse.39
Subgroup Analyses
In studies on primarily mindfulness-based inter-
ventions, moderate evidence was found for short-term 
effects on total psychotic symptoms. No such effects 
were found in studies on primarily acceptance-based 
interventions (Figure 2). Patterns were reversed for posi-
tive symptoms. Subgroups were however homogeneous, 
and no significant subgroup differences were found. 
Moderate evidence for short-term effects on mindful-
ness was revealed in studies on acceptance-based inter-
ventions and limited evidence in studies on mindful-
ness-based interventions; subgroups were homogeneous 
and not significantly different (Figure 3). Long-term 
effects on total symptoms were revealed for mindful-
ness-based but not for acceptance-based interventions; 
subgroups were significantly different (Figure 4).
In subgroup analyses regarding diagnostic method, 
no evidence was found for short-term effects on hospital-
ization rate for studies with either manual-based diagno-
sis40  (SMD=0.47; 95% CI=0.12-1.82; P=.28) or unclear diag-
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Sensitivity Analyses
Sensitivity analyses demonstrated a significant 
effect on total psychotic symptoms and positive symp-
toms in studies with low risk of bias comparing mind-
fulness- and acceptance-based interventions to treat-
ment as usual, whereas no such effect was found in 
studies with high risk of bias. No effects were found for 
acceptance in studies with either low or high risk of 
bias while effects on mindfulness were found in both 
low-risk and high-risk studies. All other comparisons 
included only studies with low risk of bias.
DISCUSSION
Summary of Evidence 
This systematic review found moderate evidence 
for short- and long-term improvements of psychotic 
symptoms and hospitalization in patients with psy-
chotic disorders after mindfulness- and acceptance-
based interventions compared to treatment as usual. 
There were no significant subgroup differences 
between the studies on primarily acceptance-based 
interventions such as ACT or studies on primarily 
mindfulness-based interventions.
Agreement With Previous Systematic Reviews
The findings of this meta-analysis are partly in 
line with those of a previous one that found between-
group effects on negative symptoms and rehospital-
ization but not on positive symptoms for mindful-
ness- and acceptance-based interventions in patients 
with psychosis.46 While this previous meta-analysis 
included all available uncontrolled and controlled 
studies, further RCTs that were not included are now 
available. Differences between the 2 meta-analyses 
likely stem from differences in inclusion criteria and 
methods of analysis. A further systematic review on 
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mindfulness-based interventions for severe mental 
disorders concluded that these interventions might 
reduce symptom-associated distress and hospitaliza-
tion for individuals with psychotic disorders.47 The 
main difference between the previous reviews and the 
present one is the inclusion of additional RCTs, pre-
senting the most up-to-date review on the effective-
ness of mindfulness- and acceptance-based interven-
tions for psychosis in RCTs. Moreover, the previous 
reviews did not included a meta-analysis47 or did not 
separately meta-analyze effects of mindfulness- and 
acceptance-based interventions on different outcomes 
compared to different control interventions.46
Moreover, the results of the present review are 
partly comparable to those of cognitive behavior thera-
py (CBT), which shares many intervention components 
with both ACT and MBCT, for schizophrenia. These 
reviews reported effects on mental state but not on hos-
pitalization when comparing CBT to treatment as 
usual48 and effects on psychotic symptoms when com-
paring CBT to other psychological interventions.49 
However, a recent Cochrane review failed to show differ-
ences between CBT and other psychological interven-
tions on symptoms or hospitalization in patients with 
schizophrenia.50 Another systematic review that includ-
ed only high-quality RCTs on CBT for early psychosis 
concluded that CBT can improve psychotic symptoms 
but did not influence relapse or rehospitalization.51
A recent meta-analysis on yoga—which shares 
many similarities with mindfulness meditation and 
has been shown to improve cognitive function52,53—
for schizophrenia found no evidence for effects on 
psychotic symptoms or hospitalization.54
External and Internal Validity
Patients in the included studies were recruited 
from psychiatric hospitals, outpatient clinics, mental 
health services, and patient associations in North 
America, Europe, and Australia. All but 1 study37 used 
clear and well-accepted diagnostic criteria, and patients 
with different psychotic disorders were included. The 
majority of patients were males and in the reproduc-
tive-age range. The results of this review are therefore 
applicable to the vast majority of patients with psy-
chotic disorders in clinical practice.
Two out of 8 studies had high risk of bias.39,41 No 
evidence of effectiveness on primary outcomes was 
found in studies with high risk of bias while evidence 
for effects on total symptoms, positive symptoms, and 
hospitalization was found in studies with low risk of 
bias. Therefore, this evidence can be regarded as robust 
against potential methodological bias.
Strengths and Weaknesses
A major strength of this review is that, besides 
psychopathology, patient-centered outcomes were 
used.55 Most of the included studies had low risk of bias 
and the evidence of effectiveness was robust against 
potential bias. While patients were recruited from dif-
ferent facilities and it could be argued that this would 
influence severity of symptoms, all significant meta-
analyses were free of statistical heterogeneity, suggest-
ing comparability between studies.
The primary limitation of this review is the small 
total number of eligible RCTs. As no unpublished stud-
ies were included in this review and publication bias 
could not be assessed, it cannot be ruled out that fur-
ther unpublished RCTs exist that could add further and 
possibly conflicting evidence. While the included stud-
ies suggest superiority of mindfulness- and acceptance-
based interventions to treatment as usual, no studies 
were available that included a head-to-head compari-
son to other active interventions. While subgroup 
analyses were conducted to separately analyze the 
effectiveness of primarily acceptance-based and pri-
marily mindfulness-based interventions, the small 
number of RCTs in each subgroup limits their expres-
siveness. Only 2 RCTs reported data on compliance to 
antipsychotic medication, the possible influence of 
differences in compliance on trial outcomes thus could 
not be assessed. One might further question the compa-
rability of primarily mindfulness-based and primarily 
acceptance-based interventions. As outlined above, 
while these approaches share many similarities, the 
practical techniques used in each intervention might 
strongly differ. Moreover, the different approaches 
have different therapeutic foci: eg, MBCT has been 
designed as an intervention for relapse prevention in 
major depression16 and has been shown to effectively 
ameliorate recurrent depression.56 On the other hand, 
ACT has a more broad focus and has been evaluated in 
a number of psychiatric conditions.57 However, there is 
no condition yet for which effectiveness of ACT is con-
clusively established.58 Therefore, the interpretations 
of overall effects might be less valid than those of the 
subgroup analyses.
The included studies used varying interventions 
with and without concomitant medication and vary-
ing control group conditions. These factors might 
weaken the conclusions of this meta-analysis.
Implications for Further Research
While psychopharmacological treatment is the 
most important intervention for psychosis, its effec-
tiveness on negative symptoms is limited6 and a 
considerable number of patients are therapy refrac-
tory.7 Thus, patients may require adjunctive psycho-
therapeutic interventions to help them cope with 
symptoms that are not effectively treated with anti-
psychotic medication. Given the low number of 
available studies, definite conclusions about the 
effectiveness of mindfulness- and acceptance-based 
interventions for that end are impossible. However, 
in light of the preliminary evidence found in this 
review, further research seems warranted. Future 
studies should ensure rigorous methodology and 
reporting, mainly adequate randomization, alloca-
tion concealment, and intention-to treat analysis.59 
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While blinding of participants or providers might not 
be possible in interventions that involve complex 
interactions between patients and providers and 
should thus not be regarded as a lack of quality of the 
study (while it is still a possible source of bias), ade-
quate blinding of outcome assessors should be intend-
ed all the more in future studies. Besides comparisons 
with treatment as usual or attention control, head-to-
head studies are needed to compare the effects of 
mindfulness- and acceptance-based interventions 
with those of more traditional approaches—eg, cogni-
tive-behavioral interventions.
Implications for Clinical Practice
While the expressiveness of the findings of this 
meta-analysis is somewhat limited by the small num-
ber of included RCTs, the clearly positive findings are 
encouraging. No intervention-related serious adverse 
events were reported. While single cases of psychotic 
relapse after unsupervised meditation practice and 
even meditation-induced psychosis have been report-
ed,60 there seems to be little risk of relapse and aggrava-
tion of psychotic symptoms in supervised mindful-
ness- and acceptance-based interventions. Thus both 
mindfulness- and acceptance-based interventions can 
be recommended as additional treatments for patients 
with psychosis but should be closely supervised by 
adequately trained therapists.
Conclusions
This systematic review and meta-analysis found 
moderate evidence for short- and long-term effects of 
mindfulness- and acceptance-based interventions on 
psychotic symptoms, hospitalization, and mindfulness 
in patients with psychotic disorders. Both types of 
interventions can be recommended as an additional 
treatment for patients with psychosis.
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